Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M508603200 on November 10, 2005

J. Biol. Chem., Vol. 281, Issue 2, 834-842, January 13, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/2/834    most recent
M508603200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ammoun, S.
Right arrow Articles by Kukkonen, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ammoun, S.
Right arrow Articles by Kukkonen, J. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

G-protein-coupled OX1 Orexin/hcrtr-1 Hypocretin Receptors Induce Caspase-dependent and -independent Cell Death through p38 Mitogen-/Stress-activated Protein Kinase*

Sylwia Ammoun{ddagger}, Dan Lindholm§, Hanna Wootz§, Karl E. O. Åkerman{ddagger}||, and Jyrki P. Kukkonen{ddagger}1

From the {ddagger}Department of Neuroscience, Unit of Physiology, Uppsala University, SE-75123 Uppsala, Sweden, the §Department of Neuroscience, Unit of Neurobiology, Uppsala University, SE-75123 Uppsala, Sweden, the Minerva Foundation Institute for Medical Research, FIN-00290 Helsinki, Finland, and the ||A. I. Virtanen Institute for Molecular Sciences, University of Kuopio, FIN-70210 Kuopio, Finland

We have investigated the signaling of OX1 receptors to cell death using Chinese hamster ovary cells as a model system. OX1 receptor stimulation with orexin-A caused a delayed cell death independently of cytosolic Ca2+ elevation. The classical mitogen-activated protein kinase (MAPK) pathways, ERK and p38, were strongly activated by orexin-A. p38 was essential for induction of cell death, whereas the ERK pathway appeared protective. A pathway often implicated in the p38-mediated cell death, activation of p53, did not mediate the cell death, as there was no stabilization of p53 or increase in p53-dependent transcriptional activity, and dominant-negative p53 constructs did not inhibit cell demise. Under basal conditions, orexin-A-induced cell death was associated with compact chromatin condensation and it required de novo gene transcription and protein synthesis, the classical hallmarks of programmed (apoptotic) cell death. However, though the pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-(O-methyl)fluoromethyl ketone (Z-VAD-fmk) fully inhibited the caspase activity, it did not rescue the cells from orexin-A-induced death. In the presence of Z-VAD-fmk, orexin-A-induced cell death was still dependent on p38 and de novo protein synthesis, but it no longer required gene transcription. Thus, caspase inhibition causes activation of alternative, gene transcription-independent death pathway. In summary, the present study points out mechanisms for orexin receptor-mediated cell death and adds to our general understanding of the role of G-protein-coupled receptor signaling in cell death by suggesting a pathway from G-protein-coupled receptors to cell death via p38 mitogen-/stress-activated protein kinase independent of p53 and caspase activation.


Received for publication, August 4, 2005 , and in revised form, November 2, 2005.

* This work was supported by the European Union Contract QLG3-CT-2002-00826, the Cancer Research Fund of Sweden, the Lars Hierta Foundation, the Åke Wiberg Foundation, the Göran Gustafsson Foundation, the Novo Nordisk Foundation, the Mary, Åke and Hans Ländall Foundation, Uppsala University, the Academy of Finland, and the Sigrid Jusélius Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Neuroscience, Unit of Physiology, Uppsala University, BMC, P. O. Box 572, SE-75123 Uppsala, Sweden. Tel.: 46-18-4714171; Fax: 46-18-501740; E-mail: jyrki.kukkonen{at}neuro.uu.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
T. Kanazawa, P. K. Kommareddi, T. Iwashita, B. Kumar, K. Misawa, Y. Misawa, I. Jang, T. S. Nair, Y. Iino, and T. E. Carey
Galanin Receptor Subtype 2 Suppresses Cell Proliferation and Induces Apoptosis in p53 Mutant Head and Neck Cancer Cells
Clin. Cancer Res., April 1, 2009; 15(7): 2222 - 2230.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement